	Alzheimer's disease polygenic risk in early- and late-onset Alzheimer's disease. Alzheimers Dement Pentchev JV, Jackson T, Khan N, Rosewood TJ, Huang YN, Nho K, Saykin AJ, Eloyan A, Taurone A, Thangarajah M, Riddle M, Salloway S, Atri A, Honig LS, Johnson ECB, Turner RS, Masdeu JC, Foroud TM, Clark D, Hammers DB, Dage JL, Kirby K, Ghetti B, Newell K, Onyike CU, Day GS, Graff-Radford NR, Murray ME, Jones DT, Jack CR Jr, Vemuri P, Touroutoglou A, Duara R, Grant I, Sha S, Wingo TS, Beckett LA, Rogalski E, Mendez MF, Kramer J, La Joie R, Blazhenets G, Grinberg LT, Koeppe R, Wolk DA, Aisen P, Raman R, Toga A, Kukull WA, Musiek E, Womack KB, Carrillo MC, Rabinovici GD, Dickerson BC, Apostolova LG, Nudelman KNH, Longitudinal Early. PMID: 41532810 [PubMed - indexed for MEDLINE]
	Gray matter microstructure from in vivo diffusion magnetic resonance imaging reflects post mortem neuropathology severity and clinical progression of Alzheimer's disease. Alzheimers Dement Alasmar Z, Tremblay C, Moqadam R, Serrano GE, Beach TG, Atri A, Su Y, Alzheimer's Disease Neuroimaging Initiative, Zeighami Y, Dadar M. PMID: 41532780 [PubMed - indexed for MEDLINE]
	Successful strategies for supporting diverse representation in Alzheimer's disease research. Alzheimers Dement Trammell AR, Dorbin CD, Davis CP, Manzanares CM, Xu H, Zhao L, Hanfelt JJ, Alonso A, Goldstein FC, Hales CM, Golde TE, Levey AI, Parker MW, Lah JJ. PMID: 41532588 [PubMed - indexed for MEDLINE]
	Letter to the Editor about mortality from Alzheimer's disease and other dementias and its heterogeneity across states in India: findings from GBD 2021 study. Int J Surg Lu H, Yang D, Shi Y, Wang J. PMID: 41532468 [PubMed - as supplied by publisher]
	Theranostic advances in Alzheimer's disease: structure-guided design of near-infrared fluorescent probes targeting amyloid-Î² and cholinergic dysfunction. RSC Med Chem Mandloi U, Giri N, Kumar S, Modi G. PMID: 41531938 [PubMed - as supplied by publisher]
	Mild Behavioral Impairment is Associated With Incident Cognitive Decline Among Dementia-Free, Racially Diverse Older Adults: Data From the African Americans Fighting Alzheimer's in Midlife (AA-FAIM) Study. Am J Geriatr Psychiatry Open Sci Educ Pract Fischer BL, Van Hulle CA, Norton DL, Wyman MF, Ennis G, Lambrou NH, Bouges S, Gooding DC, Gleason CE. PMID: 41531459 [PubMed]
	Subjective estimation of cognitive function in mild cognitive impairment: relationship with neurodegenerative and non-degenerative factors. Psychol Med Hamilton CA, Gallagher P, Donaghy PC, Ciafone J, Firbank M, Greenfinch G, Heslegrave A, Zetterberg H, Taylor JP, Allan LM, O'Brien JT, Thomas AJ. PMID: 41531182 [PubMed - indexed for MEDLINE]
	Cerebrospinal fluid levels of neurogranin and YKL-40 in mild cognitive impairment due to Alzheimer's disease or vascular dementia. J Alzheimers Dis Andin U, Lifvergren S, Zetterberg H, Blennow K, Lundin R, Svensson J. PMID: 41530948 [PubMed - as supplied by publisher]
	Assessment of clinical factors that predict response to nabilone for agitation in Alzheimer's disease: A post hoc analysis of a randomized placebo-controlled trial. Int Psychogeriatr Feldman OJ, Herrmann N, Ruthirakuhan M, Gallagher D, L G Verhoeff NP, Kiss A, Black SE, Lanctôt KL. PMID: 41530008 [PubMed - as supplied by publisher]
	Neurotransmitter-based machine-learning model for distinguishing Alzheimer's disease and mild cognitive impairment. J Int Med Res Zhao J, Qu Z, Li Z, Zhou L, Hu Y, Yu S, Chen X, Shu H, Alzheimer. PMID: 41529922 [PubMed - indexed for MEDLINE]
	The liver as a metabolic and immune hub in Alzheimer's disease: From mechanisms to therapeutic opportunities. J Prev Alzheimers Dis Chen J, Wang L, Zhou Y, Zhao S, Chen Q, Zheng K. PMID: 41529520 [PubMed - as supplied by publisher]
	Validation of the Polish version of Addenbrooke's Cognitive Examination III in Mild Cognitive Impairment and Alzheimer's Disease Dementia. Dement Geriatr Cogn Disord Barczak A, Krempa-Kowalewska A. PMID: 41528923 [PubMed - as supplied by publisher]
	Timed 360Â° turn test in people with Alzheimer's disease: a reliability and validity study. Ir J Med Sci Soke F, Ataoglu NEE, Gulsen C, Yorulmaz DK, Gulfirat FN, Bora HAT. PMID: 41528676 [PubMed - as supplied by publisher]
	Biomarkers. Alzheimers Dement Piaszczynska W, Budak M, Rowe B, Moallemian S, Fausto BA, Ringman JM, Gluck MA. PMID: 41528304 [PubMed - indexed for MEDLINE]
	The role of astrocytes in Alzheimer's disease: Pathophysiology, biomarkers, and therapeutic potential. J Alzheimers Dis Abedin MJ, Kastanenka KV. PMID: 41527736 [PubMed - as supplied by publisher]
	Dysbiotic shift in the oral microbiota of patients with Alzheimer's disease compared to their healthy life partners-a combinatorial approach and a paired study design. Alzheimers Res Ther Weber C, Wind D, Petzsch P, Supprian T, Dilthey A, Christl J, Finzer P. PMID: 41527012 [PubMed - as supplied by publisher]
	Systemic complement factors in aging, Alzheimer's disease and other dementias: a longitudinal study over 10 years. Mol Neurodegener Fu X, Cai H, Quan S, Zhang W, Geng Y, Tian Q, Ren Z, Xu Y, An C, Li J, Chu C, Wang W, Pang Y, Wang Q, Lu L, Wang Q, Li Y, Li F, Nie S, Jia L. PMID: 41526986 [PubMed - as supplied by publisher]
	Biomarkers. Alzheimers Dement Oomens JE, Harrison TM, Dage JL, Russ KA, Zetterberg H, Jagust WJ, Foroud TM, Biber S, Mormino EC, Johnson SC. PMID: 41525500 [PubMed - indexed for MEDLINE]
	The aging gut-glia-immune axis in alzheimer's disease: microbiome-derived mediators of neuroinflammation and therapeutic innovation. Geroscience Mir PA, Kumar N, Bhutia GT, Chaudhary P, Kaur G, Gupta SK. PMID: 41525005 [PubMed - as supplied by publisher]
	The effect of GLP-1 receptor agonists on cognition in nondiabetic patients with mild cognitive impairment or alzheimer's disease: a meta-analysis of randomized controlled trials. Neurol Sci O'Mara A, Mody BP, Mammi M, Simjian T, Ghattas K, Kaliki S, Le NPM, Liew A, Migliore M, Mekary RA. PMID: 41524953 [PubMed - indexed for MEDLINE]

Articles 1 - 20 / 68636

Page 1 of 3432



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy